Geneos Wealth Management’s Invesco S&P SmallCap Health Care ETF PSCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,764
Closed -$108K 2852
2021
Q3
$108K Hold
1,764
﹤0.01% 1146
2021
Q2
$113K Sell
1,764
-2,967
-63% -$185K ﹤0.01% 1120
2021
Q1
$294K Hold
4,731
0.01% 808
2020
Q4
$290K Buy
4,731
+2,967
+168% +$148K 0.01% 702
2020
Q3
$75K Sell
1,764
-1,917
-52% -$82K ﹤0.01% 1066
2020
Q2
$142K Sell
3,681
-54
-1% -$2.07K 0.01% 778
2020
Q1
$120K Buy
3,735
+120
+3% +$4.9K 0.01% 779
2019
Q4
$155K Buy
3,615
+51
+1% +$2.06K 0.01% 793
2019
Q3
$134K Buy
3,564
+162
+5% +$6.27K 0.01% 792
2019
Q2
$133K Sell
3,402
-6,366
-65% -$241K 0.01% 806
2019
Q1
$376K Sell
9,768
-3,711
-28% -$145K 0.02% 479
2018
Q4
$480K Sell
13,479
-120
-0.9% -$4.91K 0.04% 386
2018
Q3
$636K Buy
13,599
+9,756
+254% +$448K 0.04% 334
2018
Q2
$164K Buy
+3,843
New +$156K 0.01% 615

Other funds holding PSCH

Geneos Wealth Management's PSCH Position: Q4 2021 in Review

Geneos Wealth Management sold out of Invesco S&P SmallCap Health Care ETF (PSCH) in Q4 2021, closing a stake of 1,764 shares — an estimated $108K sold.

Geneos Wealth Management first reported a position in PSCH in Q2 2018 and held it in 14 quarters. The position peaked at $636K in Q3 2018. 107 funds tracked by Wall St. Rank hold PSCH as of Q4 2021.

  • Geneos Wealth Management reported no remaining Invesco S&P SmallCap Health Care ETF position as of Q4 2021 after selling out during the quarter.
  • Geneos Wealth Management sold 1,764 Invesco S&P SmallCap Health Care ETF shares in Q4 2021, an estimated $108K.
  • Geneos Wealth Management first reported a position in Invesco S&P SmallCap Health Care ETF in Q2 2018 and held it in 14 quarters.
  • Geneos Wealth Management's Invesco S&P SmallCap Health Care ETF position peaked at $636K in Q3 2018.
  • 107 funds tracked by Wall St. Rank held Invesco S&P SmallCap Health Care ETF as of Q4 2021.

Based on Geneos Wealth Management's 13F filing for Q4 2021, filed 9 Feb 2022.